<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0438170D-1DB9-4251-B227-9E6ECE45A8CD"><gtr:id>0438170D-1DB9-4251-B227-9E6ECE45A8CD</gtr:id><gtr:name>Agrocampus Ouest</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F0218A50-2D74-431E-9B66-7B583688A24A"><gtr:id>F0218A50-2D74-431E-9B66-7B583688A24A</gtr:id><gtr:name>Kumamoto University</gtr:name><gtr:address><gtr:line1>Kumamoto University</gtr:line1><gtr:line2>Honjo 1-1-1</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Life Sciences</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0438170D-1DB9-4251-B227-9E6ECE45A8CD"><gtr:id>0438170D-1DB9-4251-B227-9E6ECE45A8CD</gtr:id><gtr:name>Agrocampus Ouest</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F0218A50-2D74-431E-9B66-7B583688A24A"><gtr:id>F0218A50-2D74-431E-9B66-7B583688A24A</gtr:id><gtr:name>Kumamoto University</gtr:name><gtr:address><gtr:line1>Kumamoto University</gtr:line1><gtr:line2>Honjo 1-1-1</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/84C138B8-98E0-423B-A64F-FD0753985ED5"><gtr:id>84C138B8-98E0-423B-A64F-FD0753985ED5</gtr:id><gtr:firstName>Masahiro</gtr:firstName><gtr:surname>Ono</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FJ013951%2F2"><gtr:id>143718F6-DA22-448A-B22B-681E3F96B232</gtr:id><gtr:title>Elucidation of the transcriptional programme of memory T cells by a systems approach</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>BB/J013951/2</gtr:grantReference><gtr:abstractText>This project aims to reveal the fundamental molecular mechanisms of immunological memory at the gene level. Immunological memory is a unique attribute of the adaptive immune system and provides extremely efficient defense against pathogens. Because the immune system has this capacity, humans and animals (including mammals, birds, and fish) can efficiently eradicate life-threatening pathogens, especially viruses, that were once encountered in the past or for which they were immunised. Thus, immunological memory is essential for maintaining health and longevity, and the control of immunological memory will provide a mean for improving the prevention and treatment of infectious diseases, and for developing effective vaccines against pathogens such as HIV. It is, however, still unclear how immunological memory is determined and maintained in the immune system. 

This study aims to reveal how immunological memory is provided by lymphocytes, especially in T cells. T cells coordinate the activities of other immune cells, and generate efficient and rapid responses to pathogens. Thus, not surprisingly, some viruses such as HIV target T cells, and thereby cause the major symptoms of acquired immune deficiency syndrome (AIDS). Memory T cells may play central roles both in immunity to pathogens and on vaccination. Research on memory T cells, however, has been difficult and will require multiple approaches, including immunology, molecular biology, and systems biology.

Thus, we will employ an integrated approach of immunology, molecular biology, genomics, and systems biology, and address how immunological memory is maintained in memory T cells at the gene level. Immunological and molecular approaches will identify which of already known molecules are involved in generation and function of memory T cells. Genomics will identify new molecular mechanisms for controlling memory T cells. The systems approach will identify the complex regulatory mechanisms between the molecules and thereby provide rigid frameworks to fully discover the mechanisms of the generation and function of memory T cells. These together will reveal the critical mechanisms that underlie T cell memory, which can then be exploited for the development of new immunosuppressive drugs and vaccine designs. 

The project is designed to swiftly transfer knowledge and technology to industry, including the pharmaceutical industry. The understanding of the mechanism of T cell memory at the gene level is important not only for scientific progress but also for patency and for the development of new immunosuppressive drugs and vaccines. We also aim to use the findings of the project to improve the efficiency of the screening processes in the development of new drugs. The combined approach of experiments and mathematical modelling in this study can be directly used for screening processes for immunomodulative drugs, which can contribute to improve the cost performance of drug development at the preclinical stage.

This study is highly multidisciplinary. The applicant is an immunologist and molecular biologist, and has recently trained for genomics and systems biology. With this background, the applicant will coordinate collaborations with mathematical modellers, statisticians, and immunologists to provide the most efficient answers to this problem. The findings of this study will benefit broad scientific communities and contribute to health and well-being of humans and animals. In addition, this study will provide novel frameworks for systems biology, which can be used in many biological areas.</gtr:abstractText><gtr:technicalSummary>The memory response is the key feature of immunological memory, where the immune system responds to antigens in a more rapid and efficient way than during the primary response. T cells are central to such adaptive responses, and memory T cells show a more rapid and efficient response upon antigenic stimulation. It is, however, still obscure how memory T cells are generated by encounter with pathogens, and how memory T cells efficiently respond to antigens and propagate activation through interacting with other T cells and antigen-presenting cells. In addition, currently memory T cells lack specific markers and can be identified only by the expression of a set of markers or their situation, which hampers the analysis of the dynamic response of memory T cells.
The major objectives of this study are to understand T cell memory as a network of proteins/genes or as a cell population, by a systems approach using time course analysis and mathematical modelling: (1) analysis of the gene regulatory mechanisms of T cell activation-related molecules in memory T cells during the memory response; (2) analysis of the propagation of the activation from memory T cells through the naive T cell pool. The dynamics of the activation of T cells will be analysed at single cell level. This will identify physiological memory T cell populations; (3) identification of the transcriptional regulations that are specific to memory T cells by time course analysis of these cells during the memory response using a novel framework of microarray analysis with a multidimensional technique. These three stand-alone approaches will elucidate the mechanisms at different levels of T cell memory, and together strengthen the biological relevance of this study. In addition, these will define memory T cells and thereby provide the basis for future studies and applications. In addition, the modelling and multidimensional frameworks to analyse memory T cells can be used in other areas of biology.</gtr:technicalSummary><gtr:potentialImpactText>The project will benefit the following groups and thereby contribute to human well-being and health, and enhance the economic competitiveness of the UK.

1) Pharmaceutical industry
The project will contribute to pharmaceutical industry by providing drug targets as well as screening methods for candidate compounds. First, the molecular mechanism of memory T cells will provide targets for immunoregulatory drugs. Second, the combined system of experiments and theories that will be established in the project can be used at the preclinical stage of development of immunosuppressive drugs. We plan to start collaborations with pharmaceutical industry and aim to realise these benefits within 2-10 years thereafter.

2) Biotechnological industry
The antibodies to key molecules in T cell memory will be widely used in immunology and related areas and their commercialisation will benefit the biotechnological industry. I will use my informal connections with biotechnological companies, starting collaborations with them in the lifetime of the project and aiming to realise these benefits within 1-3 years thereafter.

3) Immunisation practice and vaccine development
The monoclonal antibodies or molecular markers for memory T cells can be used for monitoring the effectiveness of immunisation, which will optimise immunisation plans. In addition, elucidation of the mechanisms of T cell memory will provide molecular targets for boosting the immune system, which can be exploited for vaccine development. These collectively will benefit public and global health and vaccine industry.

4) Governmental policy in public health regarding immunisation
The project will provide a modern understanding of the mechanisms of immunisation, which will make the governmental policy more effective in providing new plans for immunisation. We will liaise with the Research Council to transfer our knowledge to policy communities. This will be done within the lifetime of the project.

5) General Public
The project will benefit the health and the quality of life of the general public via three pathways: (a) improved healthcare service (see 6); (b) improved immunisation practice (see 3); and (c) in-depth understanding of immunisation. We will hold workshops to convey the frontline understanding of immunisation through educating pupils, which will improve their uptake of necessary vaccines at proper timings. We will publish the contents of these workshop to influence broad audience.

6) Health service
The project will contribute to improve health practice via three pathways. First, the findings of this project will promote studies in related clinical research areas to elucidate the molecular mechanism of immunity against pathogens. Second, the proposed project will identify drug target for controlling memory T cells to enhance immunity in aged people. The realisation of these benefits will be within 2- 10 years after the completion of the proposed project. Third, we will rapidly disseminate our findings to health and public health professionals by publishing our perspectives in medical journals for the successful development of the health service section.

7) Animal health
The project will contribute to improve health practice of animals, and thereby contribute to animal welfares, farming, and food production via three pathways: (i) effective development of vaccines (see 3); (ii) prevention and treatment of infectious disease including zoonosises. The realisation of these benefits will be within 2- 10 years after the completion of the proposed project.

8) Education and training of scientists
The project will nurture the involved post-doc and students to have a high quality research capacity by providing a wide range of skills and knowledge of experiments, modelling, and data analysis and their integration.</gtr:potentialImpactText><gtr:fund><gtr:end>2019-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2015-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>830332</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Bioengineering</gtr:department><gtr:description>Reiko J Tanaka</gtr:description><gtr:id>D9A32041-784A-47E8-A9F1-74119F2571EA</gtr:id><gtr:impact>With Dr Reiko J Tanaka in the organisation as a co-PI, I have been awarded a BBSRC IAA. 
The collaboration is multi-disciplinary involving immunology, molecular biology, mathematical modelling, multidimensional data analysis.</gtr:impact><gtr:outcomeId>56def3ba6360b5.22254827-1</gtr:outcomeId><gtr:partnerContribution>To provide mathematical analysis.</gtr:partnerContribution><gtr:piContribution>To lead a collaborative project, provide experimental data and data anlaysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Agrocampus Ouest</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>Laboratory of Applied Mathematics Agrocampus (LMA)</gtr:department><gtr:description>Julie Josse</gtr:description><gtr:id>5B326F3F-B00D-40F6-B47D-A5844B3DC1B5</gtr:id><gtr:impact>One publication (Fujii et al, J Immunol, 2016). We have applied for a BBSRC funding with Julie Josse in Agrocampus Ouest as a collaborator.</gtr:impact><gtr:outcomeId>56def309710970.95809122-1</gtr:outcomeId><gtr:partnerContribution>To provide statistical knowledge.</gtr:partnerContribution><gtr:piContribution>To lead a collaborative project, providing experimental data and performing data analysis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kumamoto</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:department>International Research Center for Medical Sciences</gtr:department><gtr:description>Visiting Associate Professorship, University of Kumamoto</gtr:description><gtr:id>CAC1DB83-E28B-479F-A819-2BEAEBECC778</gtr:id><gtr:impact>This is a multidisciplinary collaboration between immunology and haematology.</gtr:impact><gtr:outcomeId>58c68314887cb8.40493215-1</gtr:outcomeId><gtr:partnerContribution>The institute has offered me a visiting associate professorship, so that the collaboration can be further deepened to enable research visits and also apply for funding.</gtr:partnerContribution><gtr:piContribution>Dr Yorifumi Satou is a collaborator at the institute of the University. I have provided my data analysis skills to their research.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Immuno-dancing</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DB095916-96BC-4E14-BA42-1A997E048FB7</gtr:id><gtr:impact>Immuno-dancing: I have established a novel way to convey immunology to primary school pupils by combining immunology with dancing (which I have named Immuno-dancing). The session is composed of two activities: (1) 14~15 pupils dance in a ring, and thereby become a big macrophage, which is a special immune cell dedicated for eating germs; (2) to learn Division of Labour of the immune system. We make 3 groups (dendritic cells, B cells, macrophages), and each of which has 5-6 pupils. The roles are given to each groups, to understand how immune cells coordinate an immune response. We have done the Immuno-dancing in a local primary school with a great success, and will continue developing the method.</gtr:impact><gtr:outcomeId>58babf7a3997f7.59428527</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>14909</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BBSRC Impact Acceleration Account 2015-2016</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>4020012831</gtr:fundingRef><gtr:id>304F428D-3A0C-4EAE-89BD-54898AE5E8DD</gtr:id><gtr:outcomeId>565d8c0d9dd2a4.65887449</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>6000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Development of vaccine for gastrointestinal nematode parasite of livestock</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>F20C3067-E457-4D2E-B694-D6FF00B34059</gtr:id><gtr:outcomeId>58babeaf65bf78.95730336</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>8290</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Repurposing computational tools to evaluate anti-cancer immunity for development of cancer immunotherapy</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Engineering and Physical Sciences Research Council (EPSRC)</gtr:fundingOrg><gtr:id>0530A075-9F19-41AC-819D-F84C4C70D117</gtr:id><gtr:outcomeId>58babf164b5a04.05937540</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>Japan</gtr:country><gtr:currCode>JPY</gtr:currCode><gtr:currCountryCode>Japan</gtr:currCountryCode><gtr:currLang>ja_JP</gtr:currLang><gtr:description>Facility usage at the University of Tokushima, Japan</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>University of Tokushima</gtr:fundingOrg><gtr:id>D58E7D22-7A9E-4183-8EC4-BACB50D135FC</gtr:id><gtr:outcomeId>58bac7dc6ccd75.82867906</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have developed a novel technology for measuring the activities of the immune system using new transgenic reporter mice. Briefly, we established new transgenic reporter mouse strains using a unique Fluorescent protein that changes its emission spectrum spontaneously and irreversibly to report the activities of key genes for the function of the immune system, especially a special subtype of lymphocytes, T cells. Thus, our new technology can be applied to biotechnological and pharmaceutical purposes, for example, to measure the effects of treatment in vivo.</gtr:description><gtr:exploitationPathways>Two papers are in submission, and after a publication, we will start approaching the industry.</gtr:exploitationPathways><gtr:id>4DB310AB-10E4-4C71-B190-650188A41B51</gtr:id><gtr:outcomeId>56dd75f31882a3.85656359</gtr:outcomeId><gtr:sectors><gtr:sector>Agriculture, Food and Drink,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>We have adapted Canonical Correspondence Analysis to analyse immunological genomic data including microarray and RNA-sequencing data.</gtr:description><gtr:id>293E1D2B-3B62-406B-B8E0-099996CA9599</gtr:id><gtr:impact>The data analysis tool has been used by the following publications: Kenefeck et al, J Clin Inv, 2015; Sahni et al, Oncotarget, 2015; Sinclair et al, Immunol Cell Biol, 2015.</gtr:impact><gtr:outcomeId>56dd80c7c7ea28.82551973</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Canonical Correspondence Analysis</gtr:title><gtr:type>Data analysis technique</gtr:type><gtr:url>http://bmcgenomics.biomedcentral.com/articles/10.1186/1471-2164-15-1028</gtr:url><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A novel transgenic reporter method has been developed using a unique fluorescent protein that changes its emission spectrum spontaneously (Fluorescent Timer protein, developed by Subach et al, 2009). My group has generated the first Timer reporter transgenic mouse strains using the Timer gene as a reporter gene. Furthermore, my group has established new computational methods to analyse the data that Timer reporter mice generate.</gtr:description><gtr:id>BEA0F20D-BEA2-4436-A838-997AFA15510F</gtr:id><gtr:impact>? Three research fundings have been successfully applied with proposal using the new Timer reporter technology.
?&amp;nbsp;Two papers are in submission.
?&amp;nbsp;Six abstract have been chosen for oral presentation in three conferences: the annual meeting of the British Society for Immunology, Liverpool, December 2016; the World Immune Regulation Meeting XI, Davos, 15th March 2017; the annual meeting of the American Association of Immunologists, Washington,</gtr:impact><gtr:outcomeId>58bac3207f16a0.87491397</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Timer reporter technology</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A novel multidimensional genomic analysis method has been developed to investigate the function and differentiation of T cell subsets at genomics level by adapting a multidimensional method, Canonical Correspondence Analysis (CCA), to genomics analysis.</gtr:description><gtr:id>052690D7-3955-40A2-8A55-2C585E1675EC</gtr:id><gtr:impact>The method has been used in 5 publications from my collaborators.</gtr:impact><gtr:outcomeId>58bac080d2d144.05034303</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Multidimensional genomic analysis method</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>92A31440-F8F2-4BCF-8A8B-0C47B873A076</gtr:id><gtr:title>A Zap70-dependent feedback circuit is essential for efficient selection of CD4 lineage thymocytes.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7ddd9c520b71fe0ea8e81914b8df9ea2"><gtr:id>7ddd9c520b71fe0ea8e81914b8df9ea2</gtr:id><gtr:otherNames>Sinclair C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>55af88f2089c31.12530536</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E11AA56C-D111-445B-BDAA-09626E8C1A33</gtr:id><gtr:title>Follicular helper T cell signature in type 1 diabetes.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc90e7d6e7df502acf92dd6c5052023c"><gtr:id>fc90e7d6e7df502acf92dd6c5052023c</gtr:id><gtr:otherNames>Kenefeck R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>55af88f23d23a8.78326476</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4C9E09A-3D6F-4CAA-91E0-0D48879B4C66</gtr:id><gtr:title>Impact of Enriched Environment on Murine T Cell Differentiation and Gene Expression Profile.</gtr:title><gtr:parentPublicationTitle>Frontiers in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ee55741c12d62837171b64f593aa57c"><gtr:id>3ee55741c12d62837171b64f593aa57c</gtr:id><gtr:otherNames>Rattazzi L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1664-3224</gtr:issn><gtr:outcomeId>588b5e515783d4.64494287</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BE1EBAE-A4E8-4C20-97A3-313FDD8DACEE</gtr:id><gtr:title>The impact of environmental enrichment on the murine inflammatory immune response.</gtr:title><gtr:parentPublicationTitle>JCI insight</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80fbdc01adef9ddf2773ecf42d99b091"><gtr:id>80fbdc01adef9ddf2773ecf42d99b091</gtr:id><gtr:otherNames>Brod S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2379-3708</gtr:issn><gtr:outcomeId>5a578976be6eb7.75559975</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D1DD2F3-07DD-4D07-A410-4F8801E124EF</gtr:id><gtr:title>Sonic Hedgehog regulates thymic epithelial cell differentiation.</gtr:title><gtr:parentPublicationTitle>Journal of autoimmunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2000a0661f58fe1fedced02406b9215e"><gtr:id>2000a0661f58fe1fedced02406b9215e</gtr:id><gtr:otherNames>Salda?a JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0896-8411</gtr:issn><gtr:outcomeId>56dd72d7cc2695.25051568</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF73A4E6-0CCD-4E7B-A55C-A609FEFF5C03</gtr:id><gtr:title>Controversies concerning thymus-derived regulatory T cells: fundamental issues and a new perspective.</gtr:title><gtr:parentPublicationTitle>Immunology and cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d441276053f7c2bef52b0266147e7d65"><gtr:id>d441276053f7c2bef52b0266147e7d65</gtr:id><gtr:otherNames>Ono M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0818-9641</gtr:issn><gtr:outcomeId>55b7aefa9fdfa8.67832104</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D6DF6D96-B8E5-4B43-B40F-3B08E140B579</gtr:id><gtr:title>Regulatory T Cells in Melanoma Revisited by a Computational Clustering of FOXP3+ T Cell Subpopulations.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a285d51466f5a3e1c30b70eee935794f"><gtr:id>a285d51466f5a3e1c30b70eee935794f</gtr:id><gtr:otherNames>Fujii H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>585d71e4f35bb3.96092721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AFB67128-45B7-40D2-9959-9F33DA2FCEE4</gtr:id><gtr:title>255 Foxp3 activation within effector T-cells controls the antigen-specific T-cell response in the contact hypersensitivity model</gtr:title><gtr:parentPublicationTitle>Journal of Investigative Dermatology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ca84e4b53564c345fafb4de5d97a134"><gtr:id>2ca84e4b53564c345fafb4de5d97a134</gtr:id><gtr:otherNames>Bending D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5a57896f0bdbe6.54094072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>63EDABD2-000E-4B3B-AB69-6E3DC9580EBF</gtr:id><gtr:title>FoxP3 partners up.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ca84e4b53564c345fafb4de5d97a134"><gtr:id>2ca84e4b53564c345fafb4de5d97a134</gtr:id><gtr:otherNames>Bending D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>5a219a277a6596.90677783</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22691193-2358-405E-A52B-7DE165E0249D</gtr:id><gtr:title>Interplay between the skin barrier and immune cells in patients with atopic dermatitis unraveled by means of mathematical modeling.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ca84e4b53564c345fafb4de5d97a134"><gtr:id>2ca84e4b53564c345fafb4de5d97a134</gtr:id><gtr:otherNames>Bending D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn><gtr:outcomeId>5a219a279d6f34.71672782</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A1AF5D8-D997-4071-9663-BCC0B4998DED</gtr:id><gtr:title>A genome wide transcriptional model of the complex response to pre-TCR signalling during thymocyte differentiation.</gtr:title><gtr:parentPublicationTitle>Oncotarget</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e77618e5da7805176e234832fdba965"><gtr:id>1e77618e5da7805176e234832fdba965</gtr:id><gtr:otherNames>Sahni H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1949-2553</gtr:issn><gtr:outcomeId>565d8834545128.86357910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>62E6BF8B-C3AF-4E22-9CA4-86C927B703DD</gtr:id><gtr:title>A temporally dynamic Foxp3 autoregulatory transcriptional circuit controls the effector Treg programme</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ca84e4b53564c345fafb4de5d97a134"><gtr:id>2ca84e4b53564c345fafb4de5d97a134</gtr:id><gtr:otherNames>Bending D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5a948c61a3a7c9.59468154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D37DDEE-583B-487A-BA86-132683CBE9D6</gtr:id><gtr:title>Differential regulation of activation and differentiation processes in CD4+ T cell populations and their single-cell level heterogeneity</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af1ca46a2c6f1eb261d76be3eb15973a"><gtr:id>af1ca46a2c6f1eb261d76be3eb15973a</gtr:id><gtr:otherNames>Bradley A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:outcomeId>5aa7d7bae55b57.88532132</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A5F4BF53-2064-4628-8A84-DF4F2317B492</gtr:id><gtr:title>An engineered cellular Timer for analysing the time domain of cellular differentiation in vivo</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2ca84e4b53564c345fafb4de5d97a134"><gtr:id>2ca84e4b53564c345fafb4de5d97a134</gtr:id><gtr:otherNames>Bending D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5a219a27298355.81085910</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FF39E21B-D63C-40E2-B4FB-55E140ABF426</gtr:id><gtr:title>Regulatory T Cells in Melanoma Revisited by a Computational Clustering of FOXP3+ T Cell Subpopulations.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a285d51466f5a3e1c30b70eee935794f"><gtr:id>a285d51466f5a3e1c30b70eee935794f</gtr:id><gtr:otherNames>Fujii H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>5698eddbc94cb7.67981018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A9677A7-03DF-4B60-ABB2-FA5DD3B2008B</gtr:id><gtr:title>Water resistance profile as a marker of skin barrier damage in atopic dermatitis patients.</gtr:title><gtr:parentPublicationTitle>Journal of dermatological science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/14ab6c1ed242c8174d7c2c8801b18d0f"><gtr:id>14ab6c1ed242c8174d7c2c8801b18d0f</gtr:id><gtr:otherNames>van Logtestijn MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0923-1811</gtr:issn><gtr:outcomeId>565d88aa21c677.24011457</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/J013951/2</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>0E84047C-9638-499C-BC32-CC56AD435848</gtr:id><gtr:grantRef>BB/J013951/1</gtr:grantRef><gtr:amount>1335112.95</gtr:amount><gtr:start>2013-02-01</gtr:start><gtr:end>2015-04-30</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>143718F6-DA22-448A-B22B-681E3F96B232</gtr:id><gtr:grantRef>BB/J013951/2</gtr:grantRef><gtr:amount>830332.09</gtr:amount><gtr:start>2015-05-01</gtr:start><gtr:end>2019-01-31</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>48D25546-6ADF-479A-8877-478CCDB1DC1F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Animal Science</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>A442BF36-F335-483E-9282-F3BB48AC2C47</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cell biology</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>9BDF80E2-029E-4505-B7EE-DB0FA633E483</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Omic sciences &amp; technologies</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>FB535BD0-E265-4C0A-8532-32DCB83A3951</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Tools, technologies &amp; methods</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>D16FDB98-8CBA-4298-8ACD-955DF734E7F5</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Cells</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E2AC43A0-F15F-4F00-8557-FB2D01D65940</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Immunology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>63F3D26F-05D5-477D-9F77-C6C8AC47C7DD</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Research approaches</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>20FF6FDE-28DB-4D9D-99E6-8470C745EA60</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Transcriptomics</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>